By-health Co Ltd
SZSE:300146
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
10.75
17.36
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
By-health Co Ltd
By-health Co Ltd
Research & Development
By-health Co Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
By-health Co Ltd
SZSE:300146
|
Research & Development
-¥169.4m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
|
Hengan International Group Company Ltd
HKEX:1044
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Shanghai Flyco Electrical Appliance Co Ltd
SSE:603868
|
Research & Development
-¥84m
|
CAGR 3-Years
8%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
Proya Cosmetics Co Ltd
SSE:603605
|
Research & Development
-¥187.1m
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
|
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
|
Research & Development
-¥278.9m
|
CAGR 3-Years
-69%
|
CAGR 5-Years
-44%
|
CAGR 10-Years
N/A
|
|
|
G
|
Giant Biogene Holding Co Ltd
HKEX:2367
|
Research & Development
-¥75m
|
CAGR 3-Years
-78%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
By-health Co Ltd
Glance View
By-health Co., Ltd., nestled in the bustling market of the nutrition and health supplements industry, has established itself as a prominent player in China's wellness sector. Founded in 1995, this Guangdong-based company has threaded its way through the evolving landscape of consumer health awareness. By-health's business model focuses on research, development, production, and sales of dietary supplements, capitalizing on the increasing demand for health products among a rising middle class. The company has been industriously bridging the gap between scientific advancements and consumer needs, investing heavily in research to ensure their products are both innovative and effective. By maintaining a diverse portfolio including vitamins, minerals, herbal supplements, and sports nutrition products, By-health has successfully tapped into a cross-section of consumers, from fitness enthusiasts to the health-conscious elderly. The company thrives on a strong distribution network that seamlessly blends traditional brick-and-mortar retail channels with robust e-commerce platforms. With an eye on international expansion, By-health hasn't shied away from extending its footprint beyond China, venturing into overseas markets with strategic partnerships and acquisitions. Their revenue streams flow primarily from domestic retail sales, but their global ventures are steadily contributing to their financial portfolio. By-health's dedication to producing high-quality supplements while educating consumers on wellness practices sets it apart in a competitive industry. This focus on quality and education not only solidifies brand loyalty but also enhances their reputation as a leader in the health supplement market, ensuring sustained growth and customer trust.
See Also
What is By-health Co Ltd's Research & Development?
Research & Development
-169.4m
CNY
Based on the financial report for Dec 31, 2023, By-health Co Ltd's Research & Development amounts to -169.4m CNY.
What is By-health Co Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-12%
Over the last year, the Research & Development growth was -14%. The average annual Research & Development growth rates for By-health Co Ltd have been -9% over the past three years , -12% over the past five years .
You don't have any saved screeners yet
